Regeneron gets $135.6 million compensatory, $271.2 million punitive damages against Amgen
MLex Summary: Amgen violated federal US antitrust laws, New York's Donnelly Act and California's Cartwright Act and engaged in tortious interference with prospective business relations when it used cross-therapeutic bundled rebates...To view the full article, register now.
Already a subscriber? Click here to view full article